Cell-Age Reset: FDA approves Life Biosciences longevity gene-therapy trial
TL;DR Summary
The FDA has greenlit a Life Biosciences gene-therapy trial aiming to nearly reset aging cells, a landmark step in longevity research led by David Sinclair.
- Exclusive: In major test for longevity field, FDA greenlights study on a 'near total reset' of cells Endpoints News
- Scientists May Have Found a Blueprint to Revive Old Cells ScienceAlert
- Can aging be treated at the cellular level? Penn Today
- Why even the healthiest people hit a wall at age 70 Big Think
- IT PAYS TO KNOW: Can We Slow the Aging Process? rafu.com
Reading Insights
Total Reads
1
Unique Readers
18
Time Saved
0 min
vs 1 min read
Condensed
75%
100 → 25 words
Want the full story? Read the original article
Read on Endpoints News